Document 0665 DOCN M9590665 TI Women seek greater influence in research, prevention policies. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. DT 9509 SO AIDS Policy Law. 1995 Mar 10;10(4):1, 8-9. Unique Identifier : AIDSLINE AIDS/95700213 AB HIV-positive cases among women are rising at such a rapid rate that by the year 2000, AIDS will be the second greatest killer of women between the ages of 18 and 44, surpassing heart disease and accidents. Womens' needs, however, are being largely ignored in the fight against this disease. Recently, AZT, a drug that was shown to help counter the HIV virus in men, has been shown to cut the risk of perinatal HIV infection by two-thirds in a trial on pregnant women. Some women, however, do not trust the study's findings because they worry that AZT may turn out to be the thalidomide of the 1990s. Until AIDS symptoms were defined as including uniquely female complications, women were left out of access to publicly-funded medical care and government disability benefits. Additionally, health care providers are not doing enough to help newly diagnosed women deal with the problems of domestic violence, abuse, and intimidation. Karen Rothenberg, of the University of Maryland School of Law, states that HIV-positive women are more apt to fear loss of their social structures, such as marriage, partnership or family, than economic complications, such as loss of employment or health insurance. DE *Acquired Immunodeficiency Syndrome/DRUG THERAPY/EPIDEMIOLOGY/ *PREVENTION & CONTROL Adolescence Adult Contact Tracing Diagnostic Errors *Health Policy Health Services Needs and Demand Human Incidence Physician-Patient Relations *Research Sexual Partners Women's Health Zidovudine/THERAPEUTIC USE NEWSLETTER ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).